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Diet, physical activity, and health-related outcomes of endometrial cancer survivors in 
a behavioural lifestyle programme: the Diet and Exercise in Uterine Cancer Survivors 




To explore the effectiveness of a theory-based behavioural lifestyle intervention on health 
behaviours and quality of life (QoL) in endometrial cancer survivors (ECS).  
Methods/materials 
This was a secondary analysis of a randomised controlled pilot trial conducted in two UK 
hospitals enrolling disease-free stage I-IVA ECS. Participants were allocated to an 8-week 
group-based healthy eating and physical activity intervention or usual care (UC) using 1:1 
minimisation. Participants were followed up at 8- and 24-weeks, with the 8-week assessment 
being blinded. Diet, physical activity, and QoL were measured with the Alternative Healthy 
Eating Index 2010 (AHEI-2010), Stanford 7-Day Physical Activity Recall, and the EORTC-
QLQ-C30, respectively. We analysed all eligible participants using the intention-to-treat 
approach in complete cases, adjusting for baseline values, body mass index, and age.  
Results 
We enrolled 60 of the 296 potentially eligible ECS (May - December 2015). Fifty-four eligible 
participants were randomised to the intervention (n=29) or UC (n=31), and 49 had complete 
follow-up data (n=24 in the intervention and n= 25 in UC). Intervention adherence was 77%. 
At 8-weeks, participants in the intervention improved their diet compared to UC (difference in 
AHEI-2010 score 7.5 (95% CI: 0.1, 14.9), p=0.046) but not their physical activity (0.1 MET-
h/day 95% CI: (-1.6, 1.8), p=0.879), or global QoL score (5.0 (95% CI: -3.4, 13.3), p=0.236). 
Global QoL improved in intervention participants at 24-weeks (difference 8.9 (95% CI: 0.9, 
16.8), p=0.029). No intervention-related adverse events were reported.  
Conclusions 
The potential effectiveness of the intervention appeared promising. A future fully-powered 
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Endometrial cancer affects 9,000 UK women annually, most of whom (78%) will live more than 
ten years after diagnosis.(1) However, they are the long-term cancer group with the highest 
comorbidity burden post treatment(2) who are most likely to die from cardiovascular disease.(3) 
Moreover, the prevalence of obesity and suboptimal lifestyle behaviours is high, both of which 
are associated with lower health-related quality of life (HRQoL).(4) Thus, the effect of lifestyle 
changes on outcomes after endometrial cancer treatment has been identified as one of the 
‘top ten’ endometrial cancer research priorities.(5) The early post treatment period is a key 
transition time during which women might be more motivated to engage in health behaviours 
but experience cancer-specific barriers to behaviour change.(6) Women also report a desire 
for in person advice(6) but that support is lacking post-treatment.(7) 
Behavioural lifestyle interventions improve patient-reported outcomes, such as HRQoL, in 
people living with other forms of  cancer(8, 9) and are also feasible for people after endometrial 
cancer treatment.(10, 11) We have previously adapted “Shape-Up”, an evidence- and group- 
based behavioural lifestyle intervention(12) that is already running within the health care 
system, to the particular needs and preferences of this cancer group using patient input and 
a systematic framework.(13) We piloted the programme showing acceptable feasibility and high 
participant satisfaction.(14) 
However, the potential effectiveness of such a programme is currently unclear. A recent meta-
analysis including two randomised trials of lifestyle interventions and a single arm physical 
activity intervention showed mixed results for fatigue and global quality of life (QoL) in 
endometrial cancer survivors.(15) Thus, we performed a secondary analysis of our trial to 
explore its potential effectiveness for improving health behaviours, and HRQoL and report 
standard deviations for these outcomes to allow for sample size calculations for a fully-
powered trial.(16)  
Materials and Methods 
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Trial design 
The trial protocol has been published.(17) The DEUS pilot trial was a parallel, randomised, 
controlled pilot trial with 1:1 allocation ratio to either the “Shape-Up following cancer treatment” 
intervention or care as usual. The CONSORT(18) and TIDieR(19) checklists are available as 
Supporting Information. 
Participants and recruitment 
Adult endometrial cancer (C54.1) survivors within three years of diagnosis were eligible to 
participate. Stage IVB cancer, active anti-cancer and/or palliative treatment, second primary 
cancer, lack of mental capacity to take part, severe depression, no availability for longitudinal 
follow-up, participation in a professionally delivered weight loss or exercise programme during 
the previous 6 months, performance score between 3-4(20), and inability to understand spoken 
and written English were the exclusion criteria. At the 5th week of recruitment, the inclusion 
criterion “women willing to attend all sessions” was removed given the subjective nature of its 
interpretation and the exclusion criterion “women with secondary cancer” was added to ensure 
homogeneity. Participants were recruited from two academic hospitals in London, UK between 
May and December 2015 and followed-up until June 2016; full details have been reported 
previously.(17) 
Interventions 
Shape-Up following cancer treatment  
Intervention arm participants received the “Shape-Up following cancer treatment” manual and 
participated in eight group-based weekly 1.5-hour sessions on healthy eating and physical 
activity based on Social Cognitive Theory and Control Theory.(17) In brief, the sessions focused 
on establishing a regular eating pattern, getting a healthier balance of foods, keeping an eye 
on portion sizes, reducing sedentary activity, increasing lifestyle and organised activities, and 
managing triggers to unhealthy behaviours through behavioural self-monitoring and goal 
setting, problem solving, and self-incentives. The sessions took part at University College 
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London Hospitals NHS Trust. A trained research dietitian (DAK) facilitated the face-to-face 
group discussions following a standardised scripted manual. A second researcher was 
present in all but the last group for assistance, but did not participate in the discussion. The 
remaining delivery modifications included splitting the last group into two for convenience 
purposes, and participation of an additional survivor in one of those groups to enhance the 
group experience. The sessions were audio-recorded and a researcher (RJB) was present in 
one group session to assess fidelity based on a predefined checklist.  
Care as usual 
To match currently offered usual care, participants in this arm were contacted only for the 
study assessments. They received brief standardised information and a booklet with healthy 
lifestyle advice after study completion.(21) 
Outcomes 
Diet 
The “Automated Self-Administered 24-Hour” (ASA24®) tool(22) was used for dietary 
assessment with a single weekday recall at each time point. Food records were transferred to 
the MRC Human Nutrition Unit’s in-house dietary assessment software DINO (Diet In 
Nutrients Out) dietary assessment software(23) that incorporates the UK food composition 
database, given the country-specific food nutritional composition. Methodological details are 
provided in the supplementary material. An experienced independent data analyst scientist 
(NZ) guided the process and checked 10% of entries for accuracy.  
The Alternative healthy eating index 2010 (AHEI-2010), which scores participants’ diet against 
the recommended healthy eating patterns, was calculated on a scale of 0-110 with 110 
indicating optimal diet. The score is based on 11 dietary components (vegetables, fruits, whole 
grains, sugar sweetened beverages, nuts and beans, red and processed meat, 
polyunsaturated fatty acids, long-chain omega-3 fatty acids, trans fatty acids, alcohol, salt), 
each contributing equally to the total score.(24) 
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Physical activity 
Physical activity was assessed with a 15-minute interview using the reliable, valid, and 
responsive to change Stanford 7-Day Physical Activity Recall and was calculated using 
standardised methodology.(25, 26) At the 24-week follow-up, a subsample (n=28) also wore 
ActivPal™ (PAL Technologies Ltd, Glasgow, UK) accelerometers for seven consecutive days, 
including sleep, prior to the study assessment. Using waterproof adhesive dressing, 
participants attached the device to the middle of their right thigh following standardised 
guidelines. Data were exported from the ActivPal interface program.   
Anthropometry, body composition, hand grip strength, and blood pressure 
Weight (to the nearest 0.1kg) and body composition were measured with a multi-frequency 
segmental body composition analyser (MC-980, Tanita Corp., Tokyo, Japan). Body 
composition is automatically calculated from a proprietary prediction equation. To ensure 
stable subject conditions, participants were instructed to abstain from large meals or drinks 
two hours before the assessment. They emptied their bladder immediately before the 
assessment and cleaned their limbs with sanitiser to reduce oil and sweat, which can affect 
measurement accuracy. Measurements are missing for one participant who refused to remove 
her socks. Fat free mass index (FFMI) and fat mass index (FMI) were calculated based on the 
BMI formula (Supplementary material).  
Using standardised protocols, height was measured with a stadiometer to the nearest 0.1cm 
and handgrip strength using a handgrip dynamometer (T.K.K.5401 grip – D, Takei Scientific 
Instruments, CO., LTD. Tokyo, Japan). Blood pressure was measured using an automated 
sphygmomanometer (Omron) with the participant seated comfortably for five minutes before 
measurement and their arm supported at the level of the heart. All measurements were taken 
twice and averaged for analysis. 
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Health-related quality of life (HRQoL) and health care resource use 
Participants filled out the widely used, reliable, and validated EORTC QLQ-C30(27) and 
Endometrial Cancer Module (QLQ-EN24).(28) During the final follow-up assessment, 
participants completed a questionnaire on their health care resource use within the last six 
months.(29) 
Sample size, randomisation, and blinding 
With a significance level of 5%, 64 participants (32 per arm) were needed to assess the 
feasibility of the study regarding recruitment and adherence rate with 90% power and retention 
rate with 80% power.(17) The trial was not powered to detect differences in diet, physical 
activity, and health-related outcomes, and these analyses are therefore exploratory. The 
procedures for trial arm assignment and blinding have been followed without modification as 
detailed in the protocol.(17) In brief, participants were individually allocated to each arm with 
minimisation, using BMI and age as stratified variables. The researcher (MM) assessing the 
8-week outcomes was blinded to arm allocation.  
Statistical analysis 
Following verification of assumptions (linearity, homogeneity of regression slopes, 
approximate normality of the residuals, homoscedasticity, and homogeneity of variances), 
analysis of covariance (ANCOVA) compared outcomes between the trial arms at 8-weeks 
(end of the active intervention) and at 24-weeks to explore longer term effects. Two models 
were run; an unadjusted and an adjusted one for BMI, age, and baseline values for the 
outcome of interest. The analysis followed the intention-to-treat strategy. Only eligible 
participants (n=54) were included in the complete case analysis following the recommendation 
of the Trial Steering Committee. The majority of missing data were due to non-attendance at 
follow-up. Group means are presented with standard deviations (SDs) and between group 
mean differences with 95% Cis. All analyses were carried out using the Statistical Package 




Of the 296 potentially eligible participants, 20.3% (95% CI: 15.7, 24.9) enrolled in the study. 
Recruitment was terminated early due to resource constraints. Table 1 presents baseline 
participants’ characteristics. At enrolment, the mean (± SD) age was 62.1 ± 8.3 years old, BMI 
28.0 ± 6.3kg/m2, and time since diagnosis 1.2 ± 1.0 years. More than half of participants were 
White (67%) and married (53%). The most common diagnosis was stage IA (49%), type 1 
(82%) endometrial cancer. Twenty participants adhered to the intervention based on the pre-
defined criteria.(17) The CONSORT diagram shows the trial progress (Figure 1). 
Diet, physical activity, and self-efficacy 
Changes by time and group are presented in Table 2 with ANCOVA statistics in Table S1. In 
the fully adjusted model, there was a significant improvement in the overall AHEI-2010 score 
in the active intervention group compared to control at 8-weeks (p=0.046) but not at 24-weeks 
(p=0.964). The relatively high self-efficacy score at baseline (Cronbach’s alpha=0.77) did not 
change significantly between arms at follow-up. 
Most participants (92.6%) were meeting the recommendations of at least 500 MET-minutes 
of moderate to vigorous physical activity at baseline. Furthermore, 31.5% were also meeting 
at least 500 MET-minutes of vigorous physical activity at baseline (Table S3). There was no 
evidence of a difference in the total energy expenditure or the energy expenditure from 
moderate to vigorous physical activities between groups at each time point.  
Most participants performed minimal strength and flexibility exercises throughout the study 
(Table S4). The self-reported energy expenditure was significantly positively correlated both 
with estimated energy expenditure from the accelerometer (rs=0.42, p=0.03) and with step 
count (rs=0.49, p=0.008). However, the Bland-Altman analysis (n=28) suggested that the 
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questionnaire significantly overestimated total energy expenditure compared to the 
accelerometer (mean difference=0.8 MET/h, 95% CI: -3.0, 4.7, p=0.03). 
Anthropometry, body composition, blood pressure, hand-grip strength 
Only 24.1% of participants (19.2% and 28.6% in the active intervention and usual care arm, 
respectively) were affected by obesity based on BMI at baseline. There was a statistically 
significant reduction in weight at 8-weeks for those allocated to the intervention (p=0.007) but 
not at 24-weeks (p=0.196) in the adjusted model (Table 2). This observation was also evident 
for BMI. There was no evidence of significant changes in fat mass index or fat free mass index. 
The mean systolic blood pressure was higher than the ideal 120mmHg value at baseline in 
each arm. In contrast, the mean diastolic blood pressure and handgrip strength were normal. 
No evidence of statistically significant differences between arms was obtained for these 
physical measurements, apart from handgrip strength at 24-weeks (p=0.04).  
HRQoL  
Scores for HRQoL, function scales, and symptoms are presented in Table 3 for both arms 
with their changes at each time point. Overall, the baseline scores were high for the functional 
scales and low for symptoms, except for fatigue, insomnia, and muscular pain. In the adjusted 
model, there was a statistically significant difference in the global QoL between groups at 24-
weeks (p=0.029) but not at 8-weeks (p=0.52). Those allocated to the intervention reported 
higher global QOL at 24-weeks compared those allocated to usual care. There was no 
evidence of a between group difference for the remaining HRQoL aspects, or symptoms, 
except constipation which improved significantly at 8-weeks for those allocated to the 
intervention arm (p=0.03) in the unadjusted model. Regarding the items specific to endometrial 
cancer, there was no observed significant change except a significant between-group 
improvement in the gastrointestinal symptoms at 8-weeks (p=0.02) in the unadjusted model 
(Table S5).  
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Health care resource use  
Over the study period, participants reported a mean (SD) 1.4 (1.9) visits to their GP and 1.7 
(1.6) visits to hospital outpatients, mainly in the oncology department. There were no hospital 
admissions or use of other health care services. They also reported taking on average (SD) 
1.4 (1.9) medications at the last follow-up visit. No intervention-related adverse events were 
reported. 
Discussion 
This is the first study of a health behaviour change intervention in UK endometrial cancer 
survivors indicating potential effectiveness for behaviour change and patient-reported 
outcomes. In this exploratory analysis, overall diet improved at 8-weeks, while physical activity 
remained unchanged, and weight was statistically but not clinically significantly reduced. 
Despite the wide confidence intervals, global QoL improved significantly at 24-weeks, 
approaching clinical significance.(30) 
Strengths of the study include the systematic development of the theory-based intervention 
with patient input,(13) use of a randomised design, validated outcome measures, masking of 
the 8-week assessor to intervention allocation, and medium-term follow-up. The intervention 
fits within the top ten research priorities for endometrial cancer research(5) and with the 
National Cancer Survivorship Initiative aim of delivering sustainable personalised lifestyle 
support to people with cancer.(31) Thus, a fully-powered trial should assess the potential impact 
of the intervention on the second NHS Outcome framework domain (“enhancing QoL for 
people with long term conditions”).(32) We had an excellent retention rate (91%) compared with 
the 15-20% drop out typically seen in lifestyle trials at 6 months.(33)  
Limitations of the study include the small sample size, lack of power, and presence of multiple 
testing that render the interpretation of all secondary outcomes as preliminary. However, the 
study provides a rich dataset for estimation of outcome measures for an efficacy trial. For 
example, a trial of 108 participants randomised 1:1 to the intervention or usual care would 
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provide definitive evidence of 12-point clinically significant improvement of global QoL 
assuming a standard deviation of 19, 90% power, and a=0.05. The definitive trial should also 
be powered for sustained behaviour change. Using the same assumptions, a total sample size 
of 98 participants would be needed to detect a clinically significant 10-point increase in the 
AHEI index (SD=15) and a sample of 120 to detect an increase of 30 minutes in weekly 
moderate to vigorous physical activity using accelerometry (SD=50). 
The 24-week assessment was unblinded and contamination of the control group has been 
reported.(14) Both physical activity and dietary data were self-reported. Using objective physical 
activity measurements in future trials would avoid the substantial overestimation of self-
reported physical activity. The single weekday 24-hour recall could not account for day-to-day 
variations in dietary intake but was sufficient to determine between group differences.(34) Diet 
was comprehensively assessed with AHEI-2010, which strongly predicts survival(24) and its 
components were targeted with the intervention. Although bioelectrical impedance falls behind 
other techniques in accuracy, it still provides a practical, non-invasive and reliable method for 
body composition estimation. Furthermore, relatively high levels of health behaviours, HRQoL 
and functioning were reported at baseline, which limits the generalisability of the findings and 
could hinder future studies with similar samples from observing differences due to ceiling 
effects. Hence, future studies should consider the implementation of potential entry cut-offs 
for HRQoL, functioning, and behavioural measures. Limited evidence suggests these ceiling 
effects might be less common in the FACT-G, which may also have stronger reliability and 
validity compared with the EORTC-QLQ-C30.(35) Thus, future trials should consider using 
multiple instruments to assess HRQoL.  
Baseline AHEI-2010 scores were comparable to those of a UK population-based study using 
the early AHEI version that indicated a negative association between AHEI adherence and 
mortality.(36) Previous studies in endometrial cancer survivors have mainly assessed fruit and 
vegetable intake as a dietary quality proxy, with similar(37) or higher(11) scores for fruit and 
vegetables. However, this approach fails to comprehensively assess various dietary 
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constituents that can affect disease risk. Therefore, future dietary assessment should consider 
an overall dietary approach.  
The significant improvement in overall diet at 8-week follow-up within the intervention arm, 
indicates the potential effectiveness of “Shape-Up following cancer treatment”. However, diet 
seemed to decline at 24-weeks indicating that a behavioural maintenance programme may be 
required. Such a programme could include similar behaviour change techniques to those 
included within the current intervention.(38) The lack of change in PA, while potentially 
attributable to ceiling effects, could also indicate that this aspect of the programme would 
benefit from greater input. In line with this, we have previously reported that participants in the 
programme suggested additions to the programme focusing on PA would be beneficial.(14)  
As the intervention promoted healthy eating and physical activity for overall health but not for 
weight loss, the combined lack of calorie restriction advice and high prevalence of participants 
with normal weight probably accounted for the lack of clinically significant weight loss. 
However, the demonstrated weight change provides confidence that the programme could 
promote avoidance of weight gain and acts as a surrogate marker of programme adherence. 
Furthermore, clinically significant weight loss might not be necessary for health benefits 
provided there is sustained practice of health behaviours.(39) 
While mostly not significant, mean differences for various HRQoL outcomes between the 
active intervention and control arms generally trended towards the expected direction, and 
those allocated to the intervention reported higher global QOL at 24 weeks compared those 
allocated to usual care. Our data are in line with the SUCCEED lifestyle weight loss trial 
showing significant improvements in fatigue and physical function between groups and in total 
QoL score within the lifestyle intervention.  
In the mission of survivorship advancement through lifestyle, health care professionals can 
play an integral role. Provision of brief lifestyle advice to endometrial cancer survivors after 
treatment and directing them to relevant resources may help facilitate lifestyle changes, as 
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survivors report being more likely to engage in behaviour change following counselling from 
their oncologist.(40) Given the time constraints during clinical appointments, interventions 
training health care professionals to deliver very brief lifestyle advice and motivate survivors 
appear feasible and acceptable.(41) Combining these interventions with the current one may 
increase intervention efficacy.  
Conclusion 
In conclusion, the self-help group intervention showed promising effectiveness. Further 
consideration should be given to improving the physical activity component and behaviour 
maintenance aspects of the intervention. A large-scale evaluation of the intervention could 
inform whether it will help endometrial cancer survivors improve their health behaviours and, 
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